Last reviewed · How we verify
glycopyrronium cloths
At a glance
| Generic name | glycopyrronium cloths |
|---|---|
| Also known as | Qbrexza Cloths |
| Sponsor | University of Utah |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Dry Mouth
- Folliculitis
- Anhidrosis
- Exacerbated asthma
- Irritant contact dermatitis
- cyst
- vertigo
- generalized fatigue
- Lupus Flare
Key clinical trials
- Qbrexza Cloths for Hyperhidrosis of Amputation Sites (PHASE2)
- Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis (PHASE2)
- A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis (PHASE2)
- An Open Label Study for Palmar Hyperhydrosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- glycopyrronium cloths CI brief — competitive landscape report
- glycopyrronium cloths updates RSS · CI watch RSS
- University of Utah portfolio CI